BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25960238)

  • 21. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2.
    Zhong H; Yang J; Zhang B; Wang X; Pei L; Zhang L; Lin Z; Wang Y; Wang C
    Cancer Biomark; 2018; 22(4):787-797. PubMed ID: 29945347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
    Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
    Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Lin R; Shen W; Zhi Y; Zhou Z
    Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
    Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
    Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression.
    Tchernitsa O; Kasajima A; Schäfer R; Kuban RJ; Ungethüm U; Györffy B; Neumann U; Simon E; Weichert W; Ebert MP; Röcken C
    J Pathol; 2010 Nov; 222(3):310-9. PubMed ID: 20726036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2.
    Zhang L; Liu X; Jin H; Guo X; Xia L; Chen Z; Bai M; Liu J; Shang X; Wu K; Pan Y; Fan D
    Cancer Lett; 2013 May; 332(1):94-101. PubMed ID: 23348698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
    Wang LP; Ma XQ; Cai JC
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3269-73. PubMed ID: 23328512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of microRNA-93 downregulation in human colon cancer.
    Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
    Ma G; Dai W; Sang A; Yang X; Gao C
    Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of miR-10b expression in gastric carcinoma.
    Wang YY; Ye ZY; Zhao ZS; Li L; Wang YX; Tao HQ; Wang HJ; He XJ
    Hum Pathol; 2013 Jul; 44(7):1278-85. PubMed ID: 23351547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas.
    Chen L; Jiang M; Yuan W; Tang H
    Acta Gastroenterol Belg; 2012 Mar; 75(1):22-7. PubMed ID: 22567743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
    J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
    Xu XD; He XJ; Tao HQ; Zhang W; Wang YY; Ye ZY; Zhao ZS
    J Surg Oncol; 2013 Sep; 108(3):197-202. PubMed ID: 23832550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.